Literature DB >> 3157710

Papulosquamous diseases: a review.

B J Fox, R B Odom.   

Abstract

Papulosquamous diseases are a heterogeneous group of disorders whose etiology primarily is unknown. The nosology of these disorders is based on a descriptive morphology of clinical lesions characterized by scaly papules and plaques. The major entities in this group include psoriasis, parapsoriasis (including pityriasis lichenoides et varioliformis acuta), lichen planus, lichen nitidus, lichen striatus, pityriasis rosea, pityriasis rubra pilaris, seborrheic dermatitis, and the Gianotti-Crosti syndrome. Many other conditions may become papulosquamous and should be considered in the differential diagnosis.

Entities:  

Mesh:

Year:  1985        PMID: 3157710     DOI: 10.1016/s0190-9622(85)70084-9

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  Palmoplantar lichen planus: A rare presentation of a common disease.

Authors:  Megan Landis; Christopher Bohyer; Soon Bahrami; Beth Brogan
Journal:  J Dermatol Case Rep       Date:  2008-03-29

2.  Clinicopathological Study of Non-Infectious Erythaematous Papulosquamous Skin Diseases.

Authors:  Sushma Hosamane; Muktha Pai; Thoppil Reba Philipose; Umaru Nayarmoole
Journal:  J Clin Diagn Res       Date:  2016-06-01

3.  Pattern of Papulosquamous Disorders in Children: A Clinico-Epidemiological Study.

Authors:  Jagriti Gandhi; Surbhi Agrawal; Shreya Gupta; Kapila Verma; Anil Mohite
Journal:  Cureus       Date:  2022-01-13

4.  Pityriasis Rubra Pilar and hypothyroidism.

Authors:  Aline Martinez Franzotti; Juliana Centofanti Dentello Avelar; Thaís Abrão Cardoso; Mario Cesar Pires; Maria do Rosário Vidigal
Journal:  An Bras Dermatol       Date:  2014 May-Jun       Impact factor: 1.896

Review 5.  Approach to Cutaneous Lymphoid Infiltrates: When to Consider Lymphoma?

Authors:  Yann Vincent Charli-Joseph; Michelle Gatica-Torres; Laura Beth Pincus
Journal:  Indian J Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.494

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.